Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

Dihydrotestosterone treatment can help penis growth in boys with 5α-reductase deficiency but doesn't fully normalize size after puberty.

Most people using minoxidil for hair loss probably won't see significant improvement.

Trichoscopy helps diagnose hair and scalp problems but isn't always definitive and should be used with other methods.

Using Platelet-Rich Plasma injections for male-pattern baldness didn't significantly improve hair growth.

2h-ICPR can help screen for insulin antibodies in type 2 diabetes patients.

Poliosis is common in severe alopecia areata but doesn't significantly affect overall prognosis.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

People with alopecia areata had lower vitamin D levels, but these levels didn't relate to many aspects of the condition.

AI can improve hair disorder diagnosis and treatment but can't replace doctors yet.

Alpha-blockers and 5-alpha reductase inhibitors don't significantly increase dementia risk.

Most skin changes during pregnancy are harmless and moles don't significantly change, but many women experience pigmentation changes due to hormones and sun exposure.

Androgens increase EPO production, finasteride doesn't significantly impact it.

Normal skin cell renewal doesn't need RAR signaling, but vitamin A-related skin thickening does.

Researchers developed a reliable way to measure hormones in urine, showing that a baldness treatment doesn't change hormone levels.

Visible light can damage skin and most sunscreens don't block it well; more research is needed on its effects and protection methods.

ChatGPT-5 can pass the endocrinology exam but isn't fully reliable for clinical decisions yet.

Women with PCOS often have more belly fat and higher insulin levels, but belly fat isn't the only cause of their insulin resistance.

Estrogen replacement can improve skin health in menopausal women but doesn't reverse sun damage or prevent hair loss.

Minoxidil and finasteride can slow hair loss and stimulate regrowth, but won't restore all lost hair or reverse complete baldness.

Fibromyalgia slightly more common in SLE patients but doesn't affect SLE activity assessments.

Larger spheroids improve hair growth, but size doesn't guarantee thicker hair.

Zinc supplements increased zinc levels in some hair loss patients but didn't significantly improve hair growth.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Computer-aided methods can speed up COVID-19 drug discovery and help find new uses for existing drugs.

The SAFE System may improve hair transplant results but isn't suitable for everyone.

Dutasteride protects dopamine neurons in Parkinson's mice, but Finasteride doesn't.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

A woman with a unique syndrome similar to TRPS has a genetic change near the TRPS1 gene, affecting its regulation.